Abstract
Adenoid cystic carcinoma (ACC) is a rare salivary gland tumor that, despite its rarity, has a significant portion of patients requiring systemic therapy due to its aggressiveness, tendency of late recurrence, and distant metastases. This tumor lacks validated biomarkers for patient stratification; however, recent evidence from next-generation sequencing investigations with samples from th…